ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,440, issued on Feb. 24, was assigned to Point Biopharma Inc. (Indianapolis).
"Radiopharmaceutical and methods" was invented by Joe McCann (Toronto).
According to the abstract* released by the U.S. Patent & Trademark Office: "The radiopharmaceutical 177Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177Lu-PSMA I&T."
The patent was filed on April 17, 2023, under Application No. 18/135,595.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect...